Form 4: Roivant Sciences Director Sells Shares
Insider Transaction (Form 4)
Meghan Fitzgerald, a Director of Roivant Sciences Ltd., sold 20,000 shares of common stock on September 8, 2026 for $39.90 per share.
Summary
- Option exercise/conversion: acquired 20,000 Common Shares at $8.80 ($176,000) on September 8, 2026; holds 62,963 after (Direct).
- Open-market sale: disposed of 20,000 Common Shares at $39.90 ($798,000) on September 8, 2026; holds 42,963 after (Direct).
- Option exercise/conversion: disposed of 20,000 Stock Option (Right to Buy) on September 8, 2026; holds 18,578 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $798,000 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Meghan Fitzgerald — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Common Shares | 20,000 | $9 | $176.0K | 62,963 |
| 2026-09-08 | Open-market sale | Common Shares | 20,000 | $40 | $798.0K | 42,963 |
| 2026-09-08 | Option exercise/conversion | Stock Option (Right to Buy) | 20,000 | — | — | 18,578 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (20,000 shares) |
| 2026-09-08 | Open-market sale (20,000 shares) |
| 2026-09-08 | Option exercise/conversion (20,000 shares) |
Keywords
insider transaction, Form 4, ROIV, Roivant Sciences Ltd., bearish, Meghan Fitzgerald
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.